학술논문
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
Document Type
Article
Author
Source
In Annals of Oncology March 2019 30(3):405-411
Subject
Language
ISSN
0923-7534